BELLUS Health Inc - Company Profile
Powered by 
All the sales intelligence you need on BELLUS Health Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how BELLUS Health Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with BELLUS Health Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on BELLUS Health Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 18 Apr 2023 | GSK Acquires BELLUS Health for Approximately USD2 Billion | Acquisition |
GSK plc
|
BELLUS Health Inc |
| 01 Oct 2022 | BELLUS Health Inc Enters Phase I Clinical Trial Agreement with Quotient Sciences Ltd for BLU-5937 (GDCT0468276) | Contract Service Agreement |
BELLUS Health Inc
|
Quotient Sciences Ltd
|
| 13 Jul 2022 | BELLUS Health Raises USD153 Million in Public Offering of Shares | Equity Offering | - |
BELLUS Health Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer